Abstract 12564: Safety, Pharmacokinetics, and Lipid Lowering Effects of the Oral, Liver-Targeted Liver X Receptor (LXR) Inverse Agonist TLC-2716 in Healthy Volunteers
Authors: Edward J Gane, Ryan S Huss, Jane Sur, Steve Weng, Eisuke Murakami, Archana Vijayakumar, Brian J Kirby, G. Mani Subramanian, Robert P Myers